Company Profile
Omnicell Stock Price, News & Analysis
- Ticker:
- OMCL
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
36.16 USD (-2.72%)
Close
Last updated: August 6, 2026
1.91B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, OMCL closed down 2.72% at $36.16. No new same-company headline was identified in the current news window.
Company overview
Business overview
Omnicell is a healthcare technology company focused on medication-management automation and hospital workflow software.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Omnicell sits in healthcare IT and medtech infrastructure.
Business Model Characteristics
Revenue comes from automation hardware, software, and recurring services used by hospitals and health systems.
Position Within the Biotechnology Landscape
Omnicell is not a biotech stock, but it is important to the healthcare stack because it helps manage medication use and workflow.
Future catalysts
Omnicell's catalysts are XT automation adoption, hospital medication-management software, and the pace of product-cycle upgrades. The business matters most when the installed base keeps expanding and recurring software gets more embedded.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Omnicell (OMCL)?
Omnicell (OMCL) most recently closed at 36.16 USD, a -2.72% move versus the previous session.
What is the market cap of Omnicell (OMCL)?
Omnicell currently has a market capitalization of 1.91B USD on BioPharmSignal.
What does Omnicell do?
Omnicell is a healthcare technology company focused on medication-management automation and hospital workflow software.
On which exchange is OMCL stock listed?
Omnicell (OMCL) is associated with NASDAQ, United States, Biopharma.
What is Omnicell?
Omnicell's catalysts are XT automation adoption, hospital medication-management software, and the pace of product-cycle upgrades.
Which conditions is Omnicell targeting with Omnicell?
Omnicell's catalysts are XT automation adoption, hospital medication-management software, and the pace of product-cycle upgrades.
How does Omnicell describe recent progress with Omnicell?
Omnicell's catalysts are XT automation adoption, hospital medication-management software, and the pace of product-cycle upgrades.
What future catalysts are investors watching for Omnicell?
Omnicell's catalysts are XT automation adoption, hospital medication-management software, and the pace of product-cycle upgrades. The business matters most when the installed base keeps expanding and recurring software gets more embedded.